CLDN18.2 binding molecule
Grant
US12595302B2
Kind: B2
Apr 07, 2026
Assignee
SANYOU BIOPHARMACEUTICALS CO., LTD.
Inventors
Yongcong Tan, Guojun Lang, Chao Kong, Chanjuan Liu, Min Deng, Qi Wu, Jing Zhang, Wenhai Zhang, Baoguo Fan
Abstract
Disclosed is a novel CLDN18.2 binding molecule. Also disclosed are a nucleic acid molecule encoding the CLDN18.2 binding molecule, an expression vector and a host cell for expressing the CLDN18.2 binding molecule. Further disclosed are a method for producing the CLDN18.2 binding molecule and use thereof.
CPC Classifications
C07K 16/28
C07K 2317/24
C07K 2317/565
C07K 2317/569
C07K 16/30
C07K 2317/22
C07K 2317/33
C07K 2317/34
C07K 2317/64
C07K 2317/732
C07K 2317/734
C07K 2317/76
C07K 2317/77
C07K 2317/92
A61P 35/00
A61K 39/00
A61K 2039/505
C12N 15/70
C12N 15/81
C12N 15/85
Filing Date
2020-05-21
Application No.
17613440
Claims
12